US$ 24.11
bpc 157 local injection near injury BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 for Ankle Injuries: Protocols,
Description
However, any pain usually passes quickly and patients can usually resume their normal activities immediately after the injection

This protects both the solution and your injection sites

Feldman HA, Johannes CB, Derby CA, et al

Some users prefer administration on an empty stomach for potentially improved absorption, but this is not required

Gauge refers to the thickness of the needle (the diameter)

Do not double the dose
